Donald B. Rice

Nammi Therapeutics, Inc. specializes in prodrug design that allows for efficient and stable incorporation into nammisomes. The American company's technology maintains immune modulating agents in an inactive state until released by intracellular esterases, and provides IP and FTO. The private company was founded by David Stover. David Stover has been the CEO since incorporation.

The RAND Corp. engages in conducting research and analysis to improve policy and decision-making. Its services include benchmarking, case study analysis, cost analysis, economic analysis, modeling, simulation, and optimization, performance measurement and measurement development, policy analysis, program evaluation, risk assessment and analysis, strategic planning, survey research, and technology assessment and development. The company was founded on May 14, 1948 and is headquartered in Santa Monica, CA.

Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA.

Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA.

Teledyne, Inc. is a technology-based manufacturing businesses. It is engaged in serving customers with specialty metals for consumer, industrial and aerospace applications; commercial and government-related aviation and electronics products and consumer and industrial products. The company was founded by Henry Singleton and George Kozmetsky in 1960 and is headquartered in Akron, OH.